Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on October 26, 2023. The report discloses corporate governance changes effective as of the filing date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on board composition changes and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased the number of Class III directors from two to three.
- New Director Election: Patrice A. Harris, M.D., M.A., was elected to fill the newly created vacancy.
- Term Details: Dr. Harris's term expires at the Company's annual meeting of stockholders in 2026.
- Committee Assignment: Dr. Harris will serve as a member of the Compliance Committee.
- Compensation: Dr. Harris will be compensated in accordance with the existing plan for non-employee directors, as detailed in the 2023 definitive proxy statement.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the qualifications and background of the newly elected director, Dr. Patrice A. Harris.
- Review the definitive proxy statement filed on April 7, 2023, for details on the non-employee director compensation plan.
- Confirm the impact of the board expansion on the Company's governance structure and Compliance Committee dynamics.